La Jolla, CA – A unique gene therapy method postpones the symptoms and nearly doubles the life span in a mouse animal model of Lou Gehrig’s disease, a research team led by the Salk Institute has found.
La Jolla, CA – An enzyme studied by scientists for years can prevent tangles of proteins from forming in the brain’s nerve cells – as occurs in patients with age-dependent Alzheimer’s disease, according to a study by investigators at the Salk Institute, Beth Israel Deaconess Medical Center and Harvard Medical School.
La Jolla, CA – A Salk Institute study provides significant new information in the process of allowing scientists to understand the function of plant genes. The study is published in the August 1 issue of Science.
La Jolla, CA – A Salk Institute scientist has been awarded a $3.3 million grant and the Jacob Javits Award from the National Institutes of Health (NIH) for his work in identifying how the immune and nervous systems interact to ward off disease, which may result in treatments for such autoimmune diseases as multiple sclerosis.
La Jolla, CA – Salk scientists have defined a new pathway that controls how plants flower in response to shaded, crowded conditions, and their findings may have implications for increasing yield in crops ranging from rice to wheat.
La Jolla, CA – A cellular receptor that helps tailor responses to stress also keeps the body lean despite high-fat diets, a Salk Institute research team has found. But this leanness only appears under certain conditions, including a high-fat diet.
La Jolla, CA – Professor Ronald Evans, the March of Dimes Chair in Molecular and Developmental Biology, has received the 2003 March of Dimes Prize in Developmental Biology for his pioneering the molecular pathways that lead to the most common chronic diseases affecting humans. He has also been awarded the Alfred P. Sloan Prize, one of three awards given annually by the General Motors Cancer Research Foundation.
La Jolla, CA – BRCA-2, a gene linked with breast and ovarian cancer, cooperates with male sex hormones to enhance its ability to activate transcription of genes, which may suppress tumor formation in normal cells, Salk Institute researchers have found.
La Jolla, CA – Manufacturing motor nerve cells may someday be possible to help restore function in victims of spinal cord injury or such diseases of motion as Parkinson’s and Lou Gehrig’s disease or post-polio syndrome, a Salk Institute research study has found.
La Jolla, CA – Thomas Albright, a Salk Institute professor of neuroscience and director of the vision center laboratory, was elected to the American Academy of Arts and Sciences. On May 5, the academy named 187 fellows and 29 foreign honorary members to the nation’s oldest learned society.
La Jolla, CA – Salk Institute Professor Fred H. Gage has been elected to the National Academy of Sciences. The election was held April 29 during the business session of the 140th annual meeting of the Academy. Election to membership in the academy is considered one of the highest honors that can be accorded a U.S. scientist or engineer.
La Jolla, CA – A cellular receptor that balances the accumulation of fat and fat burning in the body may be a new target for anti-obesity and cholesterol-fighting drugs, according to a Salk Institute study.
La Jolla, CA – A molecule that naturally degrades a protein linked to Alzheimer’s disease appears to reduce the levels of that protein by nearly 50 percent when delivered by gene therapy, researchers at the Salk Institute and UC San Diego have found in collaboration with researchers at the University of Kentucky. The findings appear in the March 15 issue of the Journal of Neuroscience.
La Jolla, CA – Research at the Salk Institute has identified a gene that may link certain pesticides and chemical weaponry to a number of neurological disorders, including the elusive Gulf War syndrome and attention deficit/hyperactivity disorder (ADHD).
La Jolla, CA – The Salk Institute for Biological Studies has been ranked as one of the nation’s leaders in molecular biology and genetics research by a publication that monitors trends and performances in basic research.
La Jolla, CA – A California research team has mapped an entire group of human enzymes, providing important information for the development of a new generation of drugs to treat cancer and other diseases. The findings will be published in the Dec. 6 issue of Science.